VANDERTIE MICHELLE L 4

Accession 0001209191-19-044014

CIK 0001383701other

View on SEC.gov Company Profile

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:13 PM ET

Size

31.6 KB

Accession

0001209191-19-044014

Insider Transaction Report

Form 4

Period: 2019-08-01

Conatus Pharmaceuticals Inc.CNAT

VANDERTIE MICHELLE L

Vice President, Finance

Transactions

Disposition to Issuer
Stock Option (Right to Buy)
2019-08-01−3,750→ 0 total
Exercise: $1.85Exp: 2026-02-03→ Common Stock (3,750 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-08-01−16,000→ 0 total
Exercise: $5.17Exp: 2028-02-03→ Common Stock (16,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-08-01−50,000→ 0 total
Exercise: $2.00Exp: 2029-02-06→ Common Stock (50,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-08-01−15,000→ 0 total
Exercise: $9.45Exp: 2024-02-06→ Common Stock (15,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-08-01−15,000→ 0 total
Exercise: $1.85Exp: 2026-02-03→ Common Stock (15,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-08-01−20,000→ 0 total
Exercise: $2.09Exp: 2026-03-23→ Common Stock (20,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-08-01−23,000→ 0 total
Exercise: $4.21Exp: 2027-01-25→ Common Stock (23,000 underlying)
Award
Restricted Stock Units
2019-08-01+86,375→ 86,375 total
→ Common Stock (86,375 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-08-01−15,000→ 0 total
Exercise: $6.40Exp: 2025-02-22→ Common Stock (15,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-08-01−15,000→ 0 total
Exercise: $9.61Exp: 2023-09-18→ Common Stock (15,000 underlying)

Footnotes (18)

[F1]Immediately exercisable.
[F10]The option was granted on January 26, 2017. 25% of the total number of shares of common stock subject to the option vested on January 26, 2018, and 1/48th of the total number of shares of common stock subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
[F11]On August 1, 2019, the Issuer canceled the option granted on January 26, 2017. In exchange for the canceled option, the Reporting Person received 11,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F12]The option was granted on February 4, 2018. 25% of the total number of shares of common stock subject to the option vested on February 2, 2019, and 1/48th of the total number of shares of common stock subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
[F13]On August 1, 2019, the Issuer canceled the option granted on February 4, 2018. In exchange for the canceled option, the Reporting Person received 8,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F14]The option was granted on February 7, 2019. 25% of the total number of shares of common stock subject to the option will vest on February 7, 2020, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
[F15]On August 1, 2019, the Issuer canceled the option granted on February 7, 2019. In exchange for the canceled option, the Reporting Person received 25,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F16]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F17]Represents 7,500 RSUs received in exchange for canceling the Reporting Person's option granted on 9/19/13; 7,500 RSUs received in exchange for canceling the Reporting Person's option granted on 2/7/14; 7,500 RSUs received in exchange for canceling the Reporting Person's option granted on 2/23/15; 7,500 RSUs received in exchange for canceling the Reporting Person's option granted on 2/4/16; 1,875 RSUs received in exchange for canceling the Reporting Person's option granted on 2/4/16; 10,000 RSUs received in exchange for canceling the Reporting Person's option granted on 3/24/16; 11,500 RSUs received in exchange for canceling the Reporting Person's option granted on 1/26/17; 8,000 RSUs received in exchange for canceling the Reporting Person's option granted on 2/4/18; and 25,000 RSUs received in exchange for canceling the Reporting Person's option granted on 2/7/19.
[F18]The restricted stock units will vest, subject to the Reporting Person's continuous service to the Issuer through the vesting date, on the first anniversary of the grant date. In addition, the restricted stock units will vest upon a Change of Control, an employee's termination without Cause, or resignation for Good Reason, as such terms are defined in the Issuer's 2013 Incentive Award Plan. Upon any other termination of service of the Reporting Person, unvested restricted stock units will be forfeited.
[F2]On August 1, 2019, the Issuer canceled the option granted on September 19, 2013. In exchange for the canceled option, the Reporting Person received 7,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F3]On August 1, 2019, the Issuer canceled the option granted on February 7, 2014. In exchange for the canceled option, the Reporting Person received 7,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F4]On August 1, 2019, the Issuer canceled the option granted on February 23, 2015. In exchange for the canceled option, the Reporting Person received 7,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F5]The option was granted on February 4, 2016. 25% of the total number of shares of common stock subject to the option vested on February 4, 2017, and 1/48th of the total number of shares of common stock subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
[F6]On August 1, 2019, the Issuer canceled the option granted on February 4, 2016. In exchange for the canceled option, the Reporting Person received 7,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F7]On August 1, 2019, the Issuer canceled the option granted on February 4, 2016. In exchange for the canceled option, the Reporting Person received 1,875 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F8]The option was granted on March 24, 2016. 25% of the total number of shares of common stock subject to the option vested on March 24, 2017, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
[F9]On August 1, 2019, the Issuer canceled the option granted on March 24, 2016. In exchange for the canceled option, the Reporting Person received 10,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Conatus Pharmaceuticals Inc.

CIK 0001383701

→

Entity typeother

Related Parties

filerCIK 0001701690

Filing Metadata

Form type: 4
Filed: Jul 31, 8:00 PM ET
Accepted: Aug 1, 4:13 PM ET
Size: 31.6 KB

View on SEC.gov